Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: RFX1 ENSDARG00000075904

.

Description

regulatory factor X, 1b (influences HLA class II expression) [Source:ZFIN;Acc:ZDB-GENE-041008-101]

Location

Chromosome 1: 54,088,563-54,107,321 reverse strand.

GRCz11:CM002885.2

About this gene

This gene has 3 transcripts (splice variants), 183 orthologues and 8 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	Flags
ENSDART00000148382.3	RFX1-201	3138	829aa	ENSDARP00000124460.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, 5' truncation in transcript evidence prevents annotation of the start of the CDS.CDS 5' incomplete,
ENSDART00000192662.1	RFX1-203	2058	580aa	ENSDARP00000148178.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000150357.2	RFX1-202	545	182aa	ENSDARP00000125409.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	5' and 3' truncations in transcript evidence prevent annotation of the start and the end of the CDS.CDS 5' and 3' incomplete,

.

Summary

.

.